TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
CADL

Candel Therapeutics Inc

Healthcare · Biotechnology

10.90$ -4.3% vs. previous close Closing price · As of: Sep 18, 2026

Ownership

Ownership Structure

Who owns Candel Therapeutics Inc (CADL)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 78.7% of the shares are freely tradable; institutional investors hold 59.8%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 59.8%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 15.6%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 78.7%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 20.6%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 77Mio.

Largest Shareholders

Institutions

Institutions CADL
Name Stake (%) Shares Change (%) Date
FMR Inc 14.36 10,987,017 +33.4 03/31/2026
RTW INVESTMENTS, LLC 8.39 6,422,018 +0.0 03/31/2026
Saturn V Capital Management LLC 4.32 3,303,686 +14.1 06/30/2026
BlackRock Inc 4.06 3,109,042 +8.6 03/31/2026
Portolan Capital Management, LLC 3.78 2,894,325 +70.7 03/31/2026
Vanguard Capital Management, LLC 3.22 2,462,757 +0.0 03/31/2026

Funds

Funds CADL
Name Stake (%) Shares Change (%) Date
Fidelity Select Biotechnology 6.36 4,864,753 +0.0 07/31/2026
Fidelity Growth Compy Commingled Pl S 3.73 2,855,227 +0.0 07/31/2026
State Street® SPDR® S&P® Biotech ETF 2.79 2,135,855 -1.1 08/31/2026
Fidelity Growth Company Fund 2.76 2,108,466 +0.0 07/31/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Insider holdings

Insider holdings CADL
Person Role Shares Value As of Type
Tak Paul Peter Chief Executive Officer 113,321 1,235,199 $ Sep 11, 2026 direct
Tyagarajan Seshu Chief Technology Officer 76,865 837,829 $ Aug 17, 2026 direct

Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.

Insiders

Insider Transactions

Insider Transactions
Date Person Role Type Shares Price Value
Sep 11, 2026 Tak Paul Peter Chief Executive Officer Sell 59,379 10.46 620,891
Sep 10, 2026 Tak Paul Peter Chief Executive Officer Sell 220,866 11.50 2,539,893
Sep 10, 2026 Tak Paul Peter Chief Executive Officer Other 125,000 1.55 193,750
Aug 17, 2026 Tyagarajan Seshu Chief Technology Officer Sell 7,000 12.00 84,000

Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?